Target
Somatostatin receptor type 2
Ligand
BDBM50075285
Substrate
n/a
Meas. Tech.
ChEBML_200682
Ki
40±n/a nM
Citation
 Pasternak, APan, YMarino, DSanderson, PEMosley, RRohrer, SPBirzin, ETHuskey, SEJacks, TSchleim, KDCheng, KSchaeffer, JMPatchett, AAYang, L Potent, orally bioavailable somatostatin agonists: good absorption achieved by urea backbone cyclization. Bioorg Med Chem Lett 9:491-6 (1999) [PubMed]
Target
Name:
Somatostatin receptor type 2
Synonyms:
SOMATOSTATIN SST2 | SRIF-1 | SS-2-R | SS2-R | SS2R | SSR2_HUMAN | SSTR2 | Somatostatin receptor type 2 (SSTR2)
Type:
Enzyme
Mol. Mass.:
41344.94
Organism:
Homo sapiens (Human)
Description:
P30874
Residue:
369
Sequence:
MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
  
Inhibitor
Name:
BDBM50075285
Synonyms:
(2R,3S)-N-(5-Amino-[1,3]dioxan-2-ylmethyl)-3-(1H-indol-3-yl)-2-{2-oxo-3-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-imidazolidin-1-yl}-butyramide | CHEMBL341646
Type:
Small organic molecule
Emp. Form.:
C30H37N7O5
Mol. Mass.:
575.6587
SMILES:
C[C@H]([C@@H](N1CCN(CCCn2c3ccccc3[nH]c2=O)C1=O)C(=O)NC[C@H]1OC[C@H](N)CO1)c1c[nH]c2ccccc12 |wU:2.2,26.28,wD:29.32,1.0,(-1.63,3.05,;-1.61,1.51,;-.27,.75,;1.05,1.53,;1.03,3.07,;3.71,3.08,;3.72,1.54,;5.06,.79,;6.38,1.56,;7.73,.81,;9.05,1.58,;9.19,3.12,;8.15,4.25,;8.62,5.71,;10.13,6.06,;11.18,4.92,;10.69,3.45,;11.48,2.12,;10.46,.97,;10.79,-.54,;2.39,.76,;2.4,-.78,;-.27,-.78,;1.27,-.79,;-1.05,-2.11,;-.3,-3.45,;-1.07,-4.77,;-.3,-6.12,;-1.09,-7.45,;-2.64,-7.43,;-3.42,-8.76,;-3.38,-6.09,;-2.61,-4.77,;-2.94,.74,;-2.93,-.8,;-4.26,-1.59,;-5.59,-.82,;-6.93,-1.59,;-8.26,-.82,;-8.26,.72,;-6.93,1.51,;-5.59,.74,)|
Structure:
Search PDB for entries with ligand similarity: